Carregando...
Myc is a prognostic biomarker and potential therapeutic target in osteosarcoma
BACKGROUND: Over the past four decades, outcomes for osteosarcoma patients have plateaued as there have been few emerging therapies showing clinical results. Thus, the identification of novel biomarkers and therapeutic strategies are urgently needed to address these primary obstacles in patient care...
Na minha lista:
| Publicado no: | Ther Adv Med Oncol |
|---|---|
| Principais autores: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7222246/ https://ncbi.nlm.nih.gov/pubmed/32426053 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835920922055 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|